APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dalteparin Sodium

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dalteparin Sodium Industry Growth and Trends Forecast to 2032

26 December 2025119 pages

Choose your research edition.

Industry ResearchDalteparin Sodium Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Dalteparin Sodium Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Dalteparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dalteparin Sodium Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dalteparin Sodium Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Dalteparin Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dalteparin Sodium include Aspen Oss, Opocrin, Pharma Action, SPL, Yino Pharma Limited, Baxter, Changshan Biochemical, Changzhou Qianhong Bio-pharma and Dongcheng Biochemicals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dalteparin Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dalteparin Sodium market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dalteparin Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dalteparin Sodium.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dalteparin Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dalteparin Sodium Market by Company

Aspen Oss

Opocrin

Pharma Action

SPL

Yino Pharma Limited

Baxter

Changshan Biochemical

Changzhou Qianhong Bio-pharma

Dongcheng Biochemicals

Dongying Tiandong Pharmaceutical

Pfizer

Nanjing King-friend

Xinbai Pharmaceuticals

Shenzhen Hepalink

Sichuan Deebio

Dalteparin Sodium Segment by Type

Tablet Dalteparin Sodium

Injection Dalteparin Sodium

Dalteparin Sodium Segment by Application

Myocardial Infarction Treatment

Hemodialysis

Others

Dalteparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dalteparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dalteparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dalteparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dalteparin Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dalteparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Dalteparin Sodium Table 2. Major Company of Injection Dalteparin Sodium Table 3. Global Dalteparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 5. Global Dalteparin Sodium Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dalteparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dalteparin Sodium Sales Market Share in Value by Type (2021-2026) Table 8. Global Dalteparin Sodium Price by Type (2021-2026) & (US$/Ton) Table 9. Global Dalteparin Sodium Sales by Type (2027-2032) & (Tons) Table 10. Global Dalteparin Sodium Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dalteparin Sodium Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dalteparin Sodium Sales Market Share in Value by Type (2027-2032) Table 13. Global Dalteparin Sodium Price by Type (2027-2032) & (US$/Ton) Table 14. North America Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 15. North America Dalteparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 17. Europe Dalteparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Dalteparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 21. Latin America Dalteparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Dalteparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 24. Dalteparin Sodium Industry Trends Table 25. Dalteparin Sodium Industry Drivers Table 26. Dalteparin Sodium Industry Opportunities and Challenges Table 27. Dalteparin Sodium Industry Restraints Table 28. Global Dalteparin Sodium Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dalteparin Sodium Revenue Market Share by Company (2021-2026) Table 30. Global Dalteparin Sodium Sales by Company (2021-2026) & (Tons) Table 31. Global Dalteparin Sodium Sales Share by Company (2021-2026) Table 32. Global Dalteparin Sodium Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Dalteparin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dalteparin Sodium Major Company Production Sites and Headquarters Table 35. Global Dalteparin Sodium Company, Product Type & Application Table 36. Global Dalteparin Sodium Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dalteparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dalteparin Sodium Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dalteparin Sodium Sales by Region (2021-2026) & (Tons) Table 41. Global Dalteparin Sodium Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dalteparin Sodium Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dalteparin Sodium Sales Market Share in Value by Region (2021-2026) Table 44. Global Dalteparin Sodium Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Dalteparin Sodium Sales by Region (2027-2032) & (Tons) Table 46. Global Dalteparin Sodium Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dalteparin Sodium Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dalteparin Sodium Sales Market Share in Value by Region (2027-2032) Table 49. Global Dalteparin Sodium Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Dalteparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 52. Global Dalteparin Sodium Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dalteparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dalteparin Sodium Sales Market Share in Value by Application (2021-2026) Table 55. Global Dalteparin Sodium Price by Application (2021-2026) & (US$/Ton) Table 56. Global Dalteparin Sodium Sales by Application (2027-2032) & (Tons) Table 57. Global Dalteparin Sodium Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dalteparin Sodium Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dalteparin Sodium Sales Market Share in Value by Application (2027-2032) Table 60. Global Dalteparin Sodium Price by Application (2027-2032) & (US$/Ton) Table 61. North America Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 62. North America Dalteparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 64. Europe Dalteparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Dalteparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 68. Latin America Dalteparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Dalteparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 71. Aspen Oss Company Information Table 72. Aspen Oss Business Overview Table 73. Aspen Oss Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Aspen Oss Dalteparin Sodium Product Portfolio Table 75. Aspen Oss Recent Development Table 76. Opocrin Company Information Table 77. Opocrin Business Overview Table 78. Opocrin Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Opocrin Dalteparin Sodium Product Portfolio Table 80. Opocrin Recent Development Table 81. Pharma Action Company Information Table 82. Pharma Action Business Overview Table 83. Pharma Action Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Pharma Action Dalteparin Sodium Product Portfolio Table 85. Pharma Action Recent Development Table 86. SPL Company Information Table 87. SPL Business Overview Table 88. SPL Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. SPL Dalteparin Sodium Product Portfolio Table 90. SPL Recent Development Table 91. Yino Pharma Limited Company Information Table 92. Yino Pharma Limited Business Overview Table 93. Yino Pharma Limited Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Yino Pharma Limited Dalteparin Sodium Product Portfolio Table 95. Yino Pharma Limited Recent Development Table 96. Baxter Company Information Table 97. Baxter Business Overview Table 98. Baxter Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Baxter Dalteparin Sodium Product Portfolio Table 100. Baxter Recent Development Table 101. Changshan Biochemical Company Information Table 102. Changshan Biochemical Business Overview Table 103. Changshan Biochemical Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Changshan Biochemical Dalteparin Sodium Product Portfolio Table 105. Changshan Biochemical Recent Development Table 106. Changzhou Qianhong Bio-pharma Company Information Table 107. Changzhou Qianhong Bio-pharma Business Overview Table 108. Changzhou Qianhong Bio-pharma Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Changzhou Qianhong Bio-pharma Dalteparin Sodium Product Portfolio Table 110. Changzhou Qianhong Bio-pharma Recent Development Table 111. Dongcheng Biochemicals Company Information Table 112. Dongcheng Biochemicals Business Overview Table 113. Dongcheng Biochemicals Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Dongcheng Biochemicals Dalteparin Sodium Product Portfolio Table 115. Dongcheng Biochemicals Recent Development Table 116. Dongying Tiandong Pharmaceutical Company Information Table 117. Dongying Tiandong Pharmaceutical Business Overview Table 118. Dongying Tiandong Pharmaceutical Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Dongying Tiandong Pharmaceutical Dalteparin Sodium Product Portfolio Table 120. Dongying Tiandong Pharmaceutical Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Pfizer Dalteparin Sodium Product Portfolio Table 125. Pfizer Recent Development Table 126. Nanjing King-friend Company Information Table 127. Nanjing King-friend Business Overview Table 128. Nanjing King-friend Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Nanjing King-friend Dalteparin Sodium Product Portfolio Table 130. Nanjing King-friend Recent Development Table 131. Xinbai Pharmaceuticals Company Information Table 132. Xinbai Pharmaceuticals Business Overview Table 133. Xinbai Pharmaceuticals Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 134. Xinbai Pharmaceuticals Dalteparin Sodium Product Portfolio Table 135. Xinbai Pharmaceuticals Recent Development Table 136. Shenzhen Hepalink Company Information Table 137. Shenzhen Hepalink Business Overview Table 138. Shenzhen Hepalink Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 139. Shenzhen Hepalink Dalteparin Sodium Product Portfolio Table 140. Shenzhen Hepalink Recent Development Table 141. Sichuan Deebio Company Information Table 142. Sichuan Deebio Business Overview Table 143. Sichuan Deebio Dalteparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 144. Sichuan Deebio Dalteparin Sodium Product Portfolio Table 145. Sichuan Deebio Recent Development Table 146. North America Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 147. North America Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 148. North America Dalteparin Sodium Sales Market Share by Country (2021-2026) Table 149. North America Dalteparin Sodium Sales Forecast by Country (2027-2032) & (Tons) Table 150. North America Dalteparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 151. North America Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Dalteparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Dalteparin Sodium Market Share by Country (2021-2026) Table 154. North America Dalteparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Dalteparin Sodium Market Share Forecast by Country (2027-2032) Table 156. Europe Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 157. Europe Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 158. Europe Dalteparin Sodium Sales Market Share by Country (2021-2026) Table 159. Europe Dalteparin Sodium Sales Forecast by Country (2027-2032) & (Tons) Table 160. Europe Dalteparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Dalteparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Dalteparin Sodium Market Share by Country (2021-2026) Table 164. Europe Dalteparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Dalteparin Sodium Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 168. Asia-Pacific Dalteparin Sodium Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Dalteparin Sodium Sales Forecast by Country (2027-2032) & (Tons) Table 170. Asia-Pacific Dalteparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Dalteparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Dalteparin Sodium Market Share by Country (2021-2026) Table 174. Asia-Pacific Dalteparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Dalteparin Sodium Market Share Forecast by Country (2027-2032) Table 176. Latin America Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 177. Latin America Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 178. Latin America Dalteparin Sodium Sales Market Share by Country (2021-2026) Table 179. Latin America Dalteparin Sodium Sales Forecast by Country (2027-2032) & (Tons) Table 180. Latin America Dalteparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Dalteparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Dalteparin Sodium Market Share by Country (2021-2026) Table 184. Latin America Dalteparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Dalteparin Sodium Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 188. Middle East and Africa Dalteparin Sodium Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Dalteparin Sodium Sales Forecast by Country (2027-2032) & (Tons) Table 190. Middle East and Africa Dalteparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Dalteparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Dalteparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Dalteparin Sodium Market Share by Country (2021-2026) Table 194. Middle East and Africa Dalteparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Dalteparin Sodium Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Dalteparin Sodium Distributors List Table 199. Dalteparin Sodium Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Dalteparin Sodium Image Figure 2. Global Dalteparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dalteparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Dalteparin Sodium Sales (2021-2032) & (Tons) Figure 5. Tablet Dalteparin Sodium Image Figure 6. Global Tablet Dalteparin Sodium Sales YoY Growth (2021-2032) & (Tons) Figure 7. Injection Dalteparin Sodium Image Figure 8. Global Injection Dalteparin Sodium Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Dalteparin Sodium Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dalteparin Sodium Market Share by Type 2025 VS 2032 Figure 11. North America Dalteparin Sodium Sales Market Share in Volume by Type in 2025 Figure 12. North America Dalteparin Sodium Sales Market Share in Value by Type in 2025 Figure 13. Europe Dalteparin Sodium Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dalteparin Sodium Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dalteparin Sodium Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dalteparin Sodium Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dalteparin Sodium Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dalteparin Sodium Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dalteparin Sodium Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dalteparin Sodium Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dalteparin Sodium Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Myocardial Infarction Treatment Image Figure 24. Global Myocardial Infarction Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 25. Hemodialysis Image Figure 26. Global Hemodialysis Sales YoY Growth (2021-2032) & (Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Dalteparin Sodium Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dalteparin Sodium Market Share by Application 2025 VS 2032 Figure 31. North America Dalteparin Sodium Sales Market Share in Volume by Application in 2025 Figure 32. North America Dalteparin Sodium Sales Market Share in Value by Application in 2025 Figure 33. Europe Dalteparin Sodium Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dalteparin Sodium Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dalteparin Sodium Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dalteparin Sodium Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dalteparin Sodium Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dalteparin Sodium Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dalteparin Sodium Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dalteparin Sodium Sales Market Share in Value by Application in 2025 Figure 41. North America Dalteparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Dalteparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dalteparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dalteparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dalteparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Dalteparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dalteparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dalteparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dalteparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Dalteparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dalteparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dalteparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dalteparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Dalteparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dalteparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dalteparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dalteparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Dalteparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dalteparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dalteparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dalteparin Sodium Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dalteparin Sodium Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Dalteparin Sodium
  • Injection Dalteparin Sodium
Applications
  • Myocardial Infarction Treatment
  • Hemodialysis
  • Others
Companies covered
  • Aspen Oss
  • Opocrin
  • Pharma Action
  • SPL
  • Yino Pharma Limited
  • Baxter
  • Changshan Biochemical
  • Changzhou Qianhong Bio-pharma
  • Dongcheng Biochemicals
  • Dongying Tiandong Pharmaceutical
  • Pfizer
  • Nanjing King-friend
  • Xinbai Pharmaceuticals
  • Shenzhen Hepalink
  • Sichuan Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dalteparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dalteparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dalteparin Sodium Market by Type
  6. 1.3.1 Tablet Dalteparin Sodium
  7. 1.3.2 Injection Dalteparin Sodium
  8. 1.4 Global Dalteparin Sodium Market Size by Type
  9. 1.4.1 Global Dalteparin Sodium Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dalteparin Sodium Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dalteparin Sodium Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dalteparin Sodium Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dalteparin Sodium Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dalteparin Sodium Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dalteparin Sodium Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dalteparin Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dalteparin Sodium Industry Trends
  2. 2.2 Dalteparin Sodium Industry Drivers
  3. 2.3 Dalteparin Sodium Industry Opportunities and Challenges
  4. 2.4 Dalteparin Sodium Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dalteparin Sodium Revenue (2021-2026)
  2. 3.2 Global Top Players by Dalteparin Sodium Sales (2021-2026)
  3. 3.3 Global Top Players by Dalteparin Sodium Price (2021-2026)
  4. 3.4 Global Dalteparin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dalteparin Sodium Major Company Production Sites & Headquarters
  6. 3.6 Global Dalteparin Sodium Company, Product Type & Application
  7. 3.7 Global Dalteparin Sodium Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dalteparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dalteparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dalteparin Sodium Tier 1, Tier 2, and Tier 3
4 Dalteparin Sodium Regional Status and Outlook
  1. 4.1 Global Dalteparin Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dalteparin Sodium Historic Market Size by Region
  3. 4.2.1 Global Dalteparin Sodium Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dalteparin Sodium Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dalteparin Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dalteparin Sodium Forecasted Market Size by Region
  7. 4.3.1 Global Dalteparin Sodium Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dalteparin Sodium Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dalteparin Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dalteparin Sodium by Application
  1. 5.1 Dalteparin Sodium Market by Application
  2. 5.1.1 Myocardial Infarction Treatment
  3. 5.1.2 Hemodialysis
  4. 5.1.3 Others
  5. 5.2 Global Dalteparin Sodium Market Size by Application
  6. 5.2.1 Global Dalteparin Sodium Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dalteparin Sodium Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dalteparin Sodium Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dalteparin Sodium Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dalteparin Sodium Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dalteparin Sodium Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dalteparin Sodium Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dalteparin Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aspen Oss
  2. 6.1.1 Aspen Oss Company Information
  3. 6.1.2 Aspen Oss Business Overview
  4. 6.1.3 Aspen Oss Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aspen Oss Dalteparin Sodium Product Portfolio
  6. 6.1.5 Aspen Oss Recent Developments
  7. 6.2 Opocrin
  8. 6.2.1 Opocrin Company Information
  9. 6.2.2 Opocrin Business Overview
  10. 6.2.3 Opocrin Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Opocrin Dalteparin Sodium Product Portfolio
  12. 6.2.5 Opocrin Recent Developments
  13. 6.3 Pharma Action
  14. 6.3.1 Pharma Action Company Information
  15. 6.3.2 Pharma Action Business Overview
  16. 6.3.3 Pharma Action Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pharma Action Dalteparin Sodium Product Portfolio
  18. 6.3.5 Pharma Action Recent Developments
  19. 6.4 SPL
  20. 6.4.1 SPL Company Information
  21. 6.4.2 SPL Business Overview
  22. 6.4.3 SPL Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SPL Dalteparin Sodium Product Portfolio
  24. 6.4.5 SPL Recent Developments
  25. 6.5 Yino Pharma Limited
  26. 6.5.1 Yino Pharma Limited Company Information
  27. 6.5.2 Yino Pharma Limited Business Overview
  28. 6.5.3 Yino Pharma Limited Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Yino Pharma Limited Dalteparin Sodium Product Portfolio
  30. 6.5.5 Yino Pharma Limited Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Dalteparin Sodium Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 Changshan Biochemical
  38. 6.7.1 Changshan Biochemical Company Information
  39. 6.7.2 Changshan Biochemical Business Overview
  40. 6.7.3 Changshan Biochemical Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changshan Biochemical Dalteparin Sodium Product Portfolio
  42. 6.7.5 Changshan Biochemical Recent Developments
  43. 6.8 Changzhou Qianhong Bio-pharma
  44. 6.8.1 Changzhou Qianhong Bio-pharma Company Information
  45. 6.8.2 Changzhou Qianhong Bio-pharma Business Overview
  46. 6.8.3 Changzhou Qianhong Bio-pharma Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Changzhou Qianhong Bio-pharma Dalteparin Sodium Product Portfolio
  48. 6.8.5 Changzhou Qianhong Bio-pharma Recent Developments
  49. 6.9 Dongcheng Biochemicals
  50. 6.9.1 Dongcheng Biochemicals Company Information
  51. 6.9.2 Dongcheng Biochemicals Business Overview
  52. 6.9.3 Dongcheng Biochemicals Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dongcheng Biochemicals Dalteparin Sodium Product Portfolio
  54. 6.9.5 Dongcheng Biochemicals Recent Developments
  55. 6.10 Dongying Tiandong Pharmaceutical
  56. 6.10.1 Dongying Tiandong Pharmaceutical Company Information
  57. 6.10.2 Dongying Tiandong Pharmaceutical Business Overview
  58. 6.10.3 Dongying Tiandong Pharmaceutical Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dongying Tiandong Pharmaceutical Dalteparin Sodium Product Portfolio
  60. 6.10.5 Dongying Tiandong Pharmaceutical Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Dalteparin Sodium Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Nanjing King-friend
  68. 6.12.1 Nanjing King-friend Company Information
  69. 6.12.2 Nanjing King-friend Business Overview
  70. 6.12.3 Nanjing King-friend Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Nanjing King-friend Dalteparin Sodium Product Portfolio
  72. 6.12.5 Nanjing King-friend Recent Developments
  73. 6.13 Xinbai Pharmaceuticals
  74. 6.13.1 Xinbai Pharmaceuticals Company Information
  75. 6.13.2 Xinbai Pharmaceuticals Business Overview
  76. 6.13.3 Xinbai Pharmaceuticals Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Xinbai Pharmaceuticals Dalteparin Sodium Product Portfolio
  78. 6.13.5 Xinbai Pharmaceuticals Recent Developments
  79. 6.14 Shenzhen Hepalink
  80. 6.14.1 Shenzhen Hepalink Company Information
  81. 6.14.2 Shenzhen Hepalink Business Overview
  82. 6.14.3 Shenzhen Hepalink Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Shenzhen Hepalink Dalteparin Sodium Product Portfolio
  84. 6.14.5 Shenzhen Hepalink Recent Developments
  85. 6.15 Sichuan Deebio
  86. 6.15.1 Sichuan Deebio Company Information
  87. 6.15.2 Sichuan Deebio Business Overview
  88. 6.15.3 Sichuan Deebio Dalteparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sichuan Deebio Dalteparin Sodium Product Portfolio
  90. 6.15.5 Sichuan Deebio Recent Developments
7 North America by Country
  1. 7.1 North America Dalteparin Sodium Sales by Country
  2. 7.1.1 North America Dalteparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dalteparin Sodium Sales by Country (2021-2026)
  4. 7.1.3 North America Dalteparin Sodium Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dalteparin Sodium Market Size by Country
  6. 7.2.1 North America Dalteparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dalteparin Sodium Market Size by Country (2021-2026)
  8. 7.2.3 North America Dalteparin Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dalteparin Sodium Sales by Country
  2. 8.1.1 Europe Dalteparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dalteparin Sodium Sales by Country (2021-2026)
  4. 8.1.3 Europe Dalteparin Sodium Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dalteparin Sodium Market Size by Country
  6. 8.2.1 Europe Dalteparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dalteparin Sodium Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dalteparin Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dalteparin Sodium Sales by Country
  2. 9.1.1 Asia-Pacific Dalteparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dalteparin Sodium Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dalteparin Sodium Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dalteparin Sodium Market Size by Country
  6. 9.2.1 Asia-Pacific Dalteparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dalteparin Sodium Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dalteparin Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dalteparin Sodium Sales by Country
  2. 10.1.1 South America Dalteparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dalteparin Sodium Sales by Country (2021-2026)
  4. 10.1.3 South America Dalteparin Sodium Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dalteparin Sodium Market Size by Country
  6. 10.2.1 South America Dalteparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dalteparin Sodium Market Size by Country (2021-2026)
  8. 10.2.3 South America Dalteparin Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dalteparin Sodium Sales by Country
  2. 11.1.1 Middle East and Africa Dalteparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dalteparin Sodium Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dalteparin Sodium Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dalteparin Sodium Market Size by Country
  6. 11.2.1 Middle East and Africa Dalteparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dalteparin Sodium Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dalteparin Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dalteparin Sodium Value Chain Analysis
  2. 12.1.1 Dalteparin Sodium Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dalteparin Sodium Production Mode & Process
  7. 12.2 Dalteparin Sodium Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dalteparin Sodium Distributors
  10. 12.2.3 Dalteparin Sodium Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst